Literature DB >> 22010190

Testing should not be done in all patients treated with clopidogrel who are undergoing percutaneous coronary intervention.

Guillaume Paré1, John W Eikelboom, Dirk Sibbing, Isabell Bernlochner, Adnan Kastrati.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 22010190     DOI： 10.1161/CIRCINTERVENTIONS.111.962142

Source DB:  PubMed          Journal:  Circ Cardiovasc Interv        ISSN： 1941-7640            Impact factor:   6.546


× No keyword cloud information.
  5 in total

Review 1.  Role of pharmacogenetics in public health and clinical health care: a SWOT analysis.

Authors:  Ritika Kapoor; Wei Chuen Tan-Koi; Yik-Ying Teo
Journal:  Eur J Hum Genet       Date:  2016-08-31       Impact factor: 4.246

Review 2.  Clopidogrel and warfarin pharmacogenetic tests: what is the evidence for use in clinical practice?

Authors:  Mohamed H A Shahin; Julie A Johnson
Journal:  Curr Opin Cardiol       Date:  2013-05       Impact factor: 2.161

Review 3.  Genetic profiles in ischaemic stroke.

Authors:  Steve Bevan; Hugh S Markus
Journal:  Curr Atheroscler Rep       Date:  2013-08       Impact factor: 5.113

Review 4.  Stroke genetics: prospects for personalized medicine.

Authors:  Hugh S Markus
Journal:  BMC Med       Date:  2012-09-27       Impact factor: 8.775

5.  High Platelet Reactivity in Patients with Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention: Randomised Controlled Trial Comparing Prasugrel and Clopidogrel.

Authors:  Tobias Geisler; Jean Booth; Elli Tavlaki; Athanasios Karathanos; Karin Müller; Michal Droppa; Meinrad Gawaz; Monica Yanez-Lopez; Simon J Davidson; Rod H Stables; Winston Banya; Azfar Zaman; Marcus Flather; Miles Dalby
Journal:  PLoS One       Date:  2015-08-28       Impact factor: 3.240
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.